Navigation Links
Former Howard Hughes Medical Institute president to speak at Oliver Smithies Nobel Symposium
Date:2/28/2012

CHAPEL HILL, N.C. - On Wednesday, March 14, Dr. Thomas Cech, Nobel Laureate in Chemistry, Distinguished Professor of Chemistry and Biochemistry at the University of Colorado, Boulder, and the former president of the Howard Hughes Medical Institute, will deliver the 2nd annual Oliver Smithies Nobel Symposium lecture.

The lecture, "Crawling out of the RNA world: ribozymes, telomerase and other non-coding RNA", will be presented from 3 p.m. to 4:30 p.m., in the Medical Biomolecular Research Building (MBRB) Auditorium 2204.

Dr. Cech was awarded the 1989 Nobel Prize in Chemistry for his discovery of the catalytic properties of RNA. Using Tetrahymena thermophila, a single-celled pond organism, Cech's research group demonstrated that RNA cut and rejoined chemical bonds in the absence of other proteins. This was the first finding showing that RNA participates in cellular reactions, rather than simply serving as a passive carrier of genetic information. His lab now studies the functions and regulation of telomerase, an enzyme that maintains the ends of chromosomes.

The lecture will be followed by the 2nd Annual Postdoctoral Research Poster Forum in the MBRB hall and lobby from 4:30-6:30 p.m.

The annual Nobel Laureate symposia were instigated by Dr. Oliver Smithies, the Nobel Laureate and Weatherspoon Eminent Distinguished Professor of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill. Dr. Smithies bequeathed a portion of his Noble Prize award to the university in order to sponsor events that will expose young researchers to high caliber scientists.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. Increased clumsiness in former welders
2. BMC awarded NIH grant to study brain abnormalities in former ELGANS patients
3. Celecoxib may prevent lung cancer in former smokers
4. Void in leadership on world water crisis cited by 20 former heads of government
5. Former HHS Secretary Tommy G. Thompson to Chair Stayhealthy Board
6. Former ASPB president leading sustainable bioenergy education project
7. BIO-key Retains Former Senior FBI Official as Strategic Advisor and Consultant
8. NOAA researchers: Blue whales re-establishing former migration patterns
9. Former NASA astronaut Bonnie J. Dunbar to speak at NJITs biomedical engineering seminar
10. Major source of radon exposure overlooked at former Ohio uranium-processing plant
11. UM receives 5th consecutive Howard Hughes Medical Institute grant for science education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology: